BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Navidea Biopharmaceuticals 

425 Metro Place Northurt
Suite 400
Dublin  Ohio  43017  U.S.A.
Phone: 614-793-7500 Fax: 614 793 7520


SEARCH JOBS


Industry
Medical Device






 Company News
Navidea Biopharmaceuticals (NAVB) Analyst Report: Long Term Market Potential Of Lymphoseek Does Not Justify Current Valuation By BrokerBank Securities, Inc. 4/11/2014 10:20:13 AM    More...
Navidea Biopharmaceuticals (NAVB) Announces Presentation Of Study Findings Of Manocept™ Platform Imaging Agent In Kaposi Sarcoma At American Association for Cancer Research Annual Meeting 4/10/2014 7:17:48 AM    More...
Navidea Biopharmaceuticals (NAVB) Provides Update On European Marketing Authorization Application For Lymphoseek® 3/20/2014 10:25:18 AM    More...
Navidea Biopharmaceuticals (NAVB) Announces Presentation Of Lymphoseek® Three-Year Recurrence And Survival Outcomes After Sentinel Lymph Node Biopsy In Patients With Breast Cancer And Melanoma 3/14/2014 8:44:15 AM    More...
Navidea Biopharmaceuticals (NAVB) Announces Fourth Quarter And Full Year 2013 Results 3/6/2014 7:26:24 AM    More...
Navidea Biopharmaceuticals (NAVB) Closes $30 Million Loan 3/6/2014 7:00:18 AM    More...
Navidea Biopharmaceuticals (NAVB) Announces Acceptance For Review Of An Additional sNDA To Further Expand Lymphoseek® Labeling 3/5/2014 8:58:44 AM    More...
Navidea Biopharmaceuticals (NAVB) To Announce Fourth Quarter And Full-Year 2013 Financial Results On Thursday, March 6, 2014 3/4/2014 6:59:49 AM    More...
Navidea Biopharmaceuticals (NAVB) Adds New Member To Board Of Directors 2/19/2014 7:20:41 AM    More...
Navidea Biopharmaceuticals (NAVB) Announces Priority Review For The sNDA To Expand Lymphoseek® Labeling For Sentinel Lymph Node Detection In Patients With Head And Neck Cancer 2/18/2014 8:06:49 AM    More...
12345678910...

//-->